Published by ChinaMNC · Xishan

Yunnan's 15th Five-Year Plan for Medicinal Herbs: What Foreign Founders Should Know

A practical breakdown of Yunnan Province's 2030 traditional Chinese medicine herb industry plan, covering variety priorities, GAP bases, under-forest cultivation, processing, market stabilization, food-medicine homology, and AI, for foreign founders building China operations.

Yunnan Maps Out Its Medicinal Herb Industry to 2030

Yunnan Province has published a plan for the traditional Chinese medicine (TCM) herb industry under its 15th Five-Year Plan framework. For foreign founders considering a China entity in agriculture, health products, cosmetics, or food, the document signals where provincial support and regulatory attention are heading. Below is a practical summary of what the plan actually says.

The Core Trade-Off: Less Land, More Value

By 2030, Yunnan expects the herb planting area to fall by 1.608 million mu, while the target for comprehensive output value rises by RMB 50 billion. The stated logic is to trade a reduction in area for gains in quality, processing, branding, and efficiency. In plain terms, the province is prioritizing value density over volume, which matters for founders evaluating upstream supply or co-investment in processing capacity.

Which Varieties Get Priority

Building on the 156 varieties listed in the 2024 edition of Yunnan's Dao-di (authentic regional) herb catalogue, the plan groups priorities into three tiers:

• Dao-di advantage varieties: the "Top Ten Yunnan Herbs," led by Panax notoginseng (sanqi). The list also includes Paris polyphylla (Dian chonglou), Erigeron breviscapus (dengzhanhua), Dendrobium officinale, Amomum villosum (sharen), Gastrodia elata (tianma), Yunnan poria, Yunnan angelica, Yunnan costus, and Gentiana rigescens.
• Health-resource varieties: the "Top Ten Health Resources" — Polygonatum kingianum (Dian huangjing), safflower, Bletilla striata, purple-skin Dendrobium, Phyllanthus emblica (Dian olive), Coix seed, Terminalia chebula, Amomum tsaoko (caoguo), ginger, and star anise.
• Potential varieties: the "Six Southern Medicines" — Amomum villosum, dragon's blood resin, Cibotium barometz, agarwood, Orthosiphon aristatus (kidney tea), and Dai bai jie.

Standardized Cultivation: How and Where

The plan targets 200 TCM herb GAP (Good Agricultural Practice) bases. A key focus is full GAP coverage for Wenshan sanqi, with GAP bases for under-forest varieties such as poria, Amomum villosum, Amomum tsaoko, and Phellodendron chinense (huangbo) advanced in an orderly way. The province also aims to develop a set of national-level high-standard herb raw material production bases.

On location, the emphasis is on under-forest cultivation and ecological planting for Dao-di herbs including sanqi, tianma, poria, Amomum villosum, Polygonatum kingianum, and Phellodendron chinense. The target is to expand ecological and under-forest planting bases to more than 6 million mu.

Processing and Higher-Value Products

Two processing layers are described. At the origin, the plan supports establishing primary processing lines in Dao-di herb production areas and high-standard raw material bases, linking GAP-base herbs with fresh-cut processing and upgrading products from raw materials to semi-industrialized inputs. Further downstream, enterprises are encouraged to build modern deep-processing lines, develop high-value-added products, and form a series of Yunnan herb health products. The plan also points to research and industrialization of daily chemical and beauty products and functional wellness products.

Market Stability and Risk Monitoring

For bulk and scarce varieties exposed to market swings — sanqi, angelica, and Paris polyphylla are named — the plan calls for market-based adjustment to smooth price volatility. It also calls for an information monitoring and early-warning system to flag industry risks such as盲目 expansion of planting and price collapses that hurt growers.

Food-Medicine Homology and Cross-Border Products

The plan calls for standards covering food-medicine homology raw materials, production and processing specifications, and related series. It targets cross-border registration and launch of 5 to 10 new products and envisions a "Yunnan Herb Food-Medicine Homology Culture Festival."

The "Yunnan Herb Brain" AI Initiative

An AI innovation application program called "Yunnan Herb Brain" is to be implemented, building an intelligent application system covering the full life cycle of medicinal herbs. The focus is on forming multi-level, multi-scenario intelligent solutions in key herb domains.

What This Means for Foreign Founders

Several practical threads stand out. First, provincial priorities are explicit about variety tiers, so a product concept tied to a listed Dao-di or health-resource variety aligns more clearly with local policy direction than an unlisted one. Second, the GAP base target and origin-processing support suggest opportunities in traceable supply chains and semi-processed inputs, rather than only raw commodity trade. Third, the food-medicine homology standards and cross-border registration target point to a pathway for consumer products, though the plan does not specify procedures or timelines.

Founders should also note what the document does not provide: no tax rates, no investment incentives, no registration steps, and no guarantees of approval. Treat it as a policy direction signal and verify operational requirements with local authorities and professional advisers.

Next Steps

Foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535 for help registering and operating a company in China.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.